Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

75.35
-1.9700-2.55%
Pre-market: 75.31-0.0400-0.05%04:23 EDT
Volume:379.16K
Turnover:28.69M
Market Cap:1.73B
PE:16.60
High:77.81
Open:77.33
Low:74.81
Close:77.32
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.41
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.90
PE(LYR):22.70

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Earning Preview: ANI Pharmaceuticals this quarter’s revenue is expected to increase by 14.88%, and institutional views are bullish

Earnings Agent
·
May 01

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

GlobeNewswire
·
Apr 24

ANI Pharmaceuticals Secures FDA Approval for Generic Orap

MT Newswires Live
·
Apr 20

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

GlobeNewswire
·
Apr 20

Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance

Simply Wall St.
·
Apr 18

ANI Pharma General Counsel Meredith Cook disposes 500 common shares worth $38,975

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13

ANI Pharmaceuticals Launches Generic Carbamazepine Capsules in US

MT Newswires Live
·
Apr 13

BUZZ-ANI Pharmaceuticals rises on US launch of generic epilepsy drug

Reuters
·
Apr 13

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

THOMSON REUTERS
·
Apr 13

Is ANI Pharmaceuticals (ANIP) Attractive Around US$80 After Recent Share Price Gains?

Simply Wall St.
·
Apr 11

ANI Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Delta, GATX, Humana

Reuters
·
Apr 08

BUZZ-ANI Pharmaceuticals jumps after launching generic heart drug

Reuters
·
Apr 08

ANI Pharmaceuticals Says US FDA Approves Isosorbide Mononitrate Tablet

MT Newswires Live
·
Apr 08

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

THOMSON REUTERS
·
Apr 08

ANI Pharmaceuticals replaces EisnerAmper with Ernst & Young as auditor

Reuters
·
Apr 08

ANI publishes Phase 4 NEW DAY ILUVIEN DME trial results in Ophthalmology journal

Reuters
·
Apr 07